دورية أكاديمية

[The dual mTORC1/2 inhibitor AZD2014 inhibits acute graft rejection in a rat liver transplantation model].

التفاصيل البيبلوغرافية
العنوان: [The dual mTORC1/2 inhibitor AZD2014 inhibits acute graft rejection in a rat liver transplantation model].
المؤلفون: Liao H; Second Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China., Wang Y; Second Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China., Xu X; Second Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China., Zhou C; Second Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China., Zhang J; Second Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China., Zhong K; Second Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China., Yang D; Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
المصدر: Nan fang yi ke da xue xue bao = Journal of Southern Medical University [Nan Fang Yi Ke Da Xue Xue Bao] 2022 Apr 20; Vol. 42 (4), pp. 598-603.
نوع المنشور: Journal Article
اللغة: Chinese
بيانات الدورية: Publisher: Nanfang yi ke da xue xue bao bian ji bu Country of Publication: China NLM ID: 101266132 Publication Model: Print Cited Medium: Print ISSN: 1673-4254 (Print) Linking ISSN: 16734254 NLM ISO Abbreviation: Nan Fang Yi Ke Da Xue Xue Bao Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Guangzhou : Nanfang yi ke da xue xue bao bian ji bu, 2005-
مواضيع طبية MeSH: Graft Rejection*/prevention & control , Liver Transplantation*, Animals ; Benzamides ; Graft Survival ; Liver/pathology ; Mechanistic Target of Rapamycin Complex 1 ; Morpholines ; Pyrimidines ; Rats ; Rats, Inbred Lew
مستخلص: Objective: To investigate the inhibitory effect of AZD2014, a dual mTORC1/2 inhibitor, against acute graft rejection in a rat model of allogeneic liver transplantation.
Methods: Liver transplantation from Lewis rat to recipient BN rat (a donor-recipient combination that was prone to induce acute graft rejection) was performed using Kamada's two-cuff technique. The recipient BN rats were randomized into 2 groups for treatment with daily intraperitoneal injection of AZD2014 (5 mg/kg, n =4) or vehicle (2.5 mL/kg, n =4) for 14 consecutive days, starting from the first day after the transplantation. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBIL) levels of the rats were measured 3 days before and at 1, 3, 5, 7, 10, and 14 days after the transplantation, and the survival time of the rats within 14 days were recorded. Immunohistochemical staining was used to examine the expressions of CD3 and Foxp3 in the liver graft, and acute graft rejection was assessed using HE staining based on the Banff schema.
Results: Three rats in the control group died within 14 days after the surgery, while no death occurred in the AZD2014 group, demonstrating a significantly longer survival time of the rats in AZD2014 group (χ 2 =4.213, P =0.04). Serum ALT, AST and TBIL levels in the control group increased progressively after the surgery and were all significantly higher than those in AZD2014 group at the same time point ( P < 0.05). Pathological examination revealed significantly worse liver graft rejection in the control group than in AZD2014 group based on assessment of the rejection index ( P < 0.01); the rats in the control group showed more serious T lymphocyte infiltration and significantly fewer Treg cells in the liver graft than those in AZD2014 group ( P < 0.01).
Conclusions: AZD2014 can effectively inhibit acute graft rejection in rats with allogeneic liver transplantation.
References: Mol Cancer Ther. 2015 Nov;14(11):2508-18. (PMID: 26358751)
Am J Transplant. 2015 Apr;15(4):891-902. (PMID: 25737114)
Nat Rev Cancer. 2018 Dec;18(12):744-757. (PMID: 30425336)
J Immunol. 2020 Oct 1;205(7):1799-1809. (PMID: 32839235)
Clin Kidney J. 2020 Dec 14;14(9):2047-2058. (PMID: 34476091)
Drug Saf. 2019 Jul;42(7):813-825. (PMID: 30868436)
Curr Opin Organ Transplant. 2014 Jun;19(3):253-60. (PMID: 24685671)
Semin Cancer Biol. 2019 Dec;59:92-111. (PMID: 31408724)
N Engl J Med. 1996 Mar 14;334(11):693-9. (PMID: 8594428)
Hepatology. 2001 May;33(5):1080-6. (PMID: 11343235)
Immunol Rev. 2020 May;295(1):15-38. (PMID: 32212344)
Aliment Pharmacol Ther. 2015 Feb;41(4):379-92. (PMID: 25496225)
Immunopharmacol Immunotoxicol. 2021 Dec;43(6):651-665. (PMID: 34415233)
Curr Cancer Drug Targets. 2016;16(4):288-304. (PMID: 26563881)
Hepatology. 1999 Dec;30(6):1434-40. (PMID: 10573522)
Transpl Immunol. 2021 Aug;67:101411. (PMID: 34020045)
Am J Cancer Res. 2014 Dec 15;5(1):125-39. (PMID: 25628925)
Cells. 2019 Dec 06;8(12):. (PMID: 31817676)
Front Immunol. 2019 Dec 19;10:2978. (PMID: 31921213)
Dig Liver Dis. 2012 Jul;44(7):610-6. (PMID: 22459565)
Cancer. 2011 Nov 15;117(22):5094-102. (PMID: 21538343)
Trends Biochem Sci. 2016 Jun;41(6):532-545. (PMID: 27161823)
J Hematol Oncol. 2019 Jul 5;12(1):71. (PMID: 31277692)
Bioorg Med Chem Lett. 2013 Mar 1;23(5):1212-6. (PMID: 23375793)
Immunity. 2009 Jun 19;30(6):832-44. (PMID: 19538929)
Nat Immunol. 2011 Apr;12(4):295-303. (PMID: 21358638)
Ann Surg. 1993 Aug;218(2):145-51. (PMID: 8393649)
Int Rev Immunol. 2015 Jan;34(1):19-33. (PMID: 24708060)
Front Immunol. 2021 May 20;12:535012. (PMID: 34093514)
Am J Transplant. 2014 Sep;14(9):2173-80. (PMID: 25307040)
فهرسة مساهمة: Keywords: AZD2014; graft rejection; liver transplantation; mTOR inhibitor
المشرفين على المادة: 0 (Benzamides)
0 (Morpholines)
0 (Pyrimidines)
0BSC3P4H5X (vistusertib)
EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1)
تواريخ الأحداث: Date Created: 20220509 Date Completed: 20220510 Latest Revision: 20231031
رمز التحديث: 20231101
مُعرف محوري في PubMed: PMC9085585
DOI: 10.12122/j.issn.1673-4254.2022.04.17
PMID: 35527497
قاعدة البيانات: MEDLINE
الوصف
تدمد:1673-4254
DOI:10.12122/j.issn.1673-4254.2022.04.17